LI
ODT

Leap Investments’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Leap Investments’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,259
Closed -$293K – 654
2019
Q3 		$293K Buy
+11,259
New +$377K 0.15% 232

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Leap Investments's ODT Position: Q4 2019 in Review

Leap Investments sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2019, closing a stake of 11,259 shares — an estimated $293K sold.

Leap Investments first reported a position in ODT in Q3 2019 and held it in 1 quarter. The position peaked at $293K in Q3 2019. 88 funds tracked by Wall St. Rank hold ODT as of Q4 2019.

  • Leap Investments reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 11,259 Odonate Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $293K.
  • Leap Investments first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Leap Investments's Odonate Therapeutics, Inc. Common Stock position peaked at $293K in Q3 2019.
  • 88 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.